Skip to content
Login
Solutions
For Commercial Leaders
For HCP Marketers
For DTC Marketers
For Omnichannel
For Medical Affairs
For Sales
For Data & Tech Leaders
How it Works
Platform
Contextual Intelligence
Strategy Orchestration
Partners & Integrations
Company
Resource Center
Solutions
For Commercial Leaders
For HCP Marketers
For DTC Marketers
For Omnichannel
For Medical Affairs
For Sales
For Data & Tech Leaders
How it Works
Platform
Contextual Intelligence
Strategy Orchestration
Partners & Integrations
Company
Resource Center
Request a Demo
Login
Solutions
For Commercial Leaders
For HCP Marketers
For DTC Marketers
For Omnichannel
For Medical Affairs
For Sales
For Data & Tech Leaders
How it Works
Platform
Contextual Intelligence
Strategy Orchestration
Partners & Integrations
Company
Resource Center
Solutions
For Commercial Leaders
For HCP Marketers
For DTC Marketers
For Omnichannel
For Medical Affairs
For Sales
For Data & Tech Leaders
How it Works
Platform
Contextual Intelligence
Strategy Orchestration
Partners & Integrations
Company
Resource Center
The PFIQ Resource Center
Browse by Type
Blog
Case Study
Information Sheet
Press
Video
Webinar
White Paper
All
Browse by Topic
AI
Artificial intelligence
Audience insights
Client voices
Commercial
Customer journeys
HCP engagement
Launch planning
Life science trends
Media efficiency
Medical affairs
MedTech
News
Next Best Action
Omnichannel
Optichannel excellence
Patient engagement
Product announcement
Therapeutic area expertise
Understanding ROI
All
AI
,
HCP engagement
,
Optichannel excellence
Harnessing End-to-End AI to Transform Customer Engagement in Pharma and Biotech
Read Now
HCP engagement
,
Media efficiency
,
Optichannel excellence
Omnichannel has reached its limit: Why marketers should invest in optichannel instead
This opinion in MM+M asks whether omnichannel has hit it's limit, especially when field and marketing silos persist, and what should come next.
AI
,
HCP engagement
,
Launch planning
,
Optichannel excellence
Optimizing pharma launches in real time
Most pharma launches miss their sales forecasts. But real-time optichannel marketing is replacing reactive postmortems and Share of Answer is becoming the new metric for success in an AI-driven landscape.
AI
,
HCP engagement
,
Life science trends
Why share of answer is the new share of voice in pharma marketing
Pharma brands must shift from Share of Voice to Share of Answer. Discover AEO strategies, paid AI media tactics, and cross-functional models for AI-driven clinical discovery.
AI
,
HCP engagement
,
Optichannel excellence
Optichannel marketing and winning the AI answer
This article explores the shift from traditional search strategies to Answer Engine Optimization (AEO) and explains what helps pharma brands earn visibility in AI-generated answers.
Load More